The landscape of managing diabetes is advancing with the emergence of skin-applied GLP-1 therapy. These novel patches offer a potentially less invasive alternative to needle administrations for individuals living with diabetes mellitus type 2 . These patches deliver glucagon-like peptide-1 directly through the skin , circumventing the requirement f